Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines
G. Vivaldi (London, United Kingdom), D. Jolliffe (London, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), F. Tydeman (London, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom)
Source: International Congress 2022 – Determinants, diagnosis and management of lung diseases in adults
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Vivaldi (London, United Kingdom), D. Jolliffe (London, United Kingdom), H. Holt (London, United Kingdom), M. Talaei (London, United Kingdom), F. Tydeman (London, United Kingdom), S. Shaheen (London, United Kingdom), A. Martineau (London, United Kingdom). Risk factors for breakthrough COVID-19 in 15,804 UK adults after primary and booster doses of SARS-CoV-2 vaccines. 3220
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|